Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.

Parkhurst MR, Robbins PF, Tran E, Prickett TD, Gartner JJ, Jia L, Ivey G, Li YF, El-Gamil M, Lalani A, Crystal JS, Sachs A, Groh E, Ray S, Ngo LT, Kivitz S, Pasetto A, Yossef R, Lowery FJ, Goff SL, Lo W, Cafri G, Deniger DC, Malekzadeh P, Ahmadzadeh M, Wunderlich JR, Somerville RPT, Rosenberg SA.

Cancer Discov. 2019 Aug;9(8):1022-1035. doi: 10.1158/2159-8290.CD-18-1494. Epub 2019 Jun 4.

PMID:
31164343
2.

Trends in Major Gastrectomy for Cancer: Frequency and Outcomes.

Groh EM, Hyun N, Check D, Heller T, Ripley RT, Hernandez JM, Graubard BI, Davis JL.

J Gastrointest Surg. 2019 Sep;23(9):1748-1757. doi: 10.1007/s11605-018-4061-x. Epub 2018 Dec 3.

PMID:
30511132
3.

Temporal Variations in Pediatric Trauma: Rationale for Altered Resource Utilization.

Groh EM, Feingold PL, Hashimoto B, McDuffie LA, Markel TA.

Am Surg. 2018 Jun 1;84(6):813-819.

PMID:
29981607
4.

Physical Examination is the Best Predictor of the Need for Abdominal Surgery in Children Following Motor Vehicle Collision.

Drucker NA, McDuffie L, Groh E, Hackworth J, Bell TM, Markel TA.

J Emerg Med. 2018 Jan;54(1):1-7. doi: 10.1016/j.jemermed.2017.08.008. Epub 2017 Nov 6.

5.

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.

Tran E, Robbins PF, Lu YC, Prickett TD, Gartner JJ, Jia L, Pasetto A, Zheng Z, Ray S, Groh EM, Kriley IR, Rosenberg SA.

N Engl J Med. 2016 Dec 8;375(23):2255-2262.

6.

Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain.

He S, Mansour MR, Zimmerman MW, Ki DH, Layden HM, Akahane K, Gjini E, de Groh ED, Perez-Atayde AR, Zhu S, Epstein JA, Look AT.

Elife. 2016 Apr 27;5. pii: e14713. doi: 10.7554/eLife.14713.

7.

MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.

Kerkar SP, Wang ZF, Lasota J, Park T, Patel K, Groh E, Rosenberg SA, Miettinen MM.

J Immunother. 2016 May;39(4):181-7. doi: 10.1097/CJI.0000000000000119.

8.

Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.

Park TS, Groh EM, Patel K, Kerkar SP, Lee CC, Rosenberg SA.

J Immunother. 2016 Jan;39(1):1-7. doi: 10.1097/CJI.0000000000000101.

9.

Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos.

Yzaguirre AD, Padmanabhan A, de Groh ED, Engleka KA, Li J, Speck NA, Epstein JA.

Elife. 2015 Oct 13;4:e07780. doi: 10.7554/eLife.07780.

10.

Evaluating the Effectiveness of a Nurse Practitioner-Led Outreach Program for Long-Term-Care Homes.

El-Masri MM, Omar A, Groh EM.

Can J Nurs Res. 2015 Sep;47(3):39-55. doi: 10.1177/084456211504700304. English, French.

PMID:
29509472
11.

Modulation of cAMP and ras signaling pathways improves distinct behavioral deficits in a zebrafish model of neurofibromatosis type 1.

Wolman MA, de Groh ED, McBride SM, Jongens TA, Granato M, Epstein JA.

Cell Rep. 2014 Sep 11;8(5):1265-70. doi: 10.1016/j.celrep.2014.07.054. Epub 2014 Aug 28.

12.

Kidney regeneration: common themes from the embryo to the adult.

Cirio MC, de Groh ED, de Caestecker MP, Davidson AJ, Hukriede NA.

Pediatr Nephrol. 2014 Apr;29(4):553-64. doi: 10.1007/s00467-013-2597-2. Epub 2013 Sep 5. Review.

13.

Zebrafish neurofibromatosis type 1 genes have redundant functions in tumorigenesis and embryonic development.

Shin J, Padmanabhan A, de Groh ED, Lee JS, Haidar S, Dahlberg S, Guo F, He S, Wolman MA, Granato M, Lawson ND, Wolfe SA, Kim SH, Solnica-Krezel L, Kanki JP, Ligon KL, Epstein JA, Look AT.

Dis Model Mech. 2012 Nov;5(6):881-94. doi: 10.1242/dmm.009779. Epub 2012 Jul 5.

14.

Inhibition of histone deacetylase expands the renal progenitor cell population.

de Groh ED, Swanhart LM, Cosentino CC, Jackson RL, Dai W, Kitchens CA, Day BW, Smithgall TE, Hukriede NA.

J Am Soc Nephrol. 2010 May;21(5):794-802. doi: 10.1681/ASN.2009080851. Epub 2010 Apr 8.

15.

Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.

Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE.

Clin Cancer Res. 2009 Sep 1;15(17):5338-49. doi: 10.1158/1078-0432.CCR-08-2865. Epub 2009 Aug 25.

16.

High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.

Argraves KM, Gazzolo PJ, Groh EM, Wilkerson BA, Matsuura BS, Twal WO, Hammad SM, Argraves WS.

J Biol Chem. 2008 Sep 5;283(36):25074-81. doi: 10.1074/jbc.M801214200. Epub 2008 Jul 7.

17.

Scalable and concise synthesis of dichlorofluorescein derivatives displaying tissue permeation in live zebrafish embryos.

Koide K, Song F, de Groh ED, Garner AL, Mitchell VD, Davidson LA, Hukriede NA.

Chembiochem. 2008 Jan 25;9(2):214-8. No abstract available.

18.

Cyclin D3 action in androgen receptor regulation and prostate cancer.

Olshavsky NA, Groh EM, Comstock CE, Morey LM, Wang Y, Revelo MP, Burd C, Meller J, Knudsen KE.

Oncogene. 2008 May 15;27(22):3111-21. Epub 2007 Dec 17.

PMID:
18084330
19.

Functional analysis of the hepatic HMG-CoA reductase promoter by in vivo electroporation.

Lagor WR, Heller R, de Groh ED, Ness GC.

Exp Biol Med (Maywood). 2007 Mar;232(3):353-61.

PMID:
17327468
20.

Diabetes alters the occupancy of the hepatic 3-hydroxy-3-methylglutaryl-CoA reductase promoter.

Lagor WR, de Groh ED, Ness GC.

J Biol Chem. 2005 Nov 4;280(44):36601-8. Epub 2005 Aug 26.

21.

The efficacy and side effects of continuous infusion intravenous morphine (CIVM) for pain and symptoms due to advanced cancer.

Glare P, Walsh D, Groh E, Nelson KA.

Am J Hosp Palliat Care. 2002 Sep-Oct;19(5):343-50.

PMID:
12269781
22.

Decalcification of the aortic valve does not prevent early recalcification.

Dahm M, Dohmen G, Groh E, Krummenauer F, Hafner G, Mayer E, Hake U, Oelert H.

J Heart Valve Dis. 2000 Jan;9(1):21-6.

PMID:
10678372
23.

Pathophysiology of early failure of autologous aortic heart valves (ATCV).

Dahm M, Prüfer D, Dohmen G, Mayer E, Groh E, Choi YH, Oelert H.

Thorac Cardiovasc Surg. 1998 Dec;46(6):344-7.

PMID:
9928855
24.

In vitro effects of anticalcification treatment on the calcium uptake of bioprosthetic materials.

Dahm M, Prüfer D, Krummenauer F, Mayer E, Hafner G, Groh E, Oelert H.

J Heart Valve Dis. 1998 May;7(3):336-9.

PMID:
9651849
25.

Early failure of an autologous pericardium aortic heart valve (ATCV) prosthesis.

Dahm M, Prüfer D, Mayer E, Groh E, Choi YH, Oelert H.

J Heart Valve Dis. 1998 Jan;7(1):30-3.

PMID:
9502136
26.

A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain.

Nelson KA, Glare PA, Walsh D, Groh ES.

J Pain Symptom Manage. 1997 May;13(5):262-7.

PMID:
9185431
27.

Effects of surface seeding with vital cells on the calcium uptake of biological materials for heart valve replacement.

Dahm M, Prüfer D, Mayer E, Hafner G, Groh E, Oelert H.

J Heart Valve Dis. 1996 Mar;5(2):148-51.

PMID:
8665006
28.

Relevance of immunologic reactions for tissue failure of bioprosthetic heart valves.

Dahm M, Husmann M, Eckhard-Mayer, Prüfer D, Groh E, Oelert H.

Ann Thorac Surg. 1995 Aug;60(2 Suppl):S348-52.

PMID:
7646186
29.

[Mucin-like carcinoma-associated antigen: sensitivity and specificity in metastatic breast cancer].

Ammon A, Eiffert H, Alhusen R, Weber M, Rümelin B, Groh E, Bartsch H, Marschner N, Nagel GA, Krieger G.

Onkologie. 1990 Jun;13(3):210-4. German.

PMID:
2204009
30.

Obsidian hydration dating applied to basaltic volcanic activity.

Higgins MW, Waters AC, Friedman I, Peterson NV, Groh EA.

Science. 1972 Jun 16;176(4040):1259-60. No abstract available.

PMID:
17790419

Supplemental Content

Support Center